"Targeted Prostate Cancer Screening May Cut UK Deaths by 13%, Experts Say"

A new study indicates that targeted prostate cancer screening could reduce deaths by 13% in the United Kingdom, prompting a potential screening program decision by health experts.

• Published in The New England Journal of Medicine, the study shows that a targeted approach to prostate cancer screening may significantly lower mortality rates.
• Experts are particularly concerned about overdiagnosis and unnecessary health care associated with prostate-specific antigen tests, which could lead to overtreatment.
• The National Health Service is expected to make a decision on implementing a prostate cancer screening program in the United Kingdom before the years end.